HFpEF

·MeSH: Hypertrophy, Left Ventricular

8 drugs in development·5 companies·5 clinical trials

Drug Pipeline by Phase

Phase 3(4)

Phase 2(3)

Drug	Company
ck-4021586 (150 mg	CYTOKINETICS INC (CYTK)
EDG-15400	Edgewise Therapeutics, Inc. (EWTX)
tx45	Tectonic Therapeutic, Inc. (TECX)

Phase 1/Phase 2(1)

Drug	Company
tn-301	Tenaya Therapeutics, Inc. (TNYA)

BioSniper tracks 8 drugs in development for HFpEF across 5 companies.

There are 5 clinical trials targeting HFpEF tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.